JBCHEPHARM Statistics

Total Valuation

J. B. Chemicals & Pharmaceuticals has a market cap or net worth of INR 269.35 billion. The enterprise value is 266.18 billion.

Market Cap	269.35B
Enterprise Value	266.18B

Important Dates

The last earnings date was Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	Aug 14, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.87%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	71.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.59, with an EV/FCF ratio of 39.59.

EV / Earnings	43.56
EV / Sales	7.17
EV / EBITDA	27.59
EV / EBIT	32.84
EV / FCF	39.59

Financial Position

The company has a current ratio of 3.08, with a Debt / Equity ratio of 0.03.

Current Ratio	3.08
Quick Ratio	1.98
Debt / Equity	0.03
Debt / EBITDA	0.10
Debt / FCF	0.15
Interest Coverage	28.02

Financial Efficiency

Return on equity (ROE) is 20.62% and return on invested capital (ROIC) is 15.64%.

Return on Equity (ROE)	20.62%
Return on Assets (ROA)	12.94%
Return on Capital (ROIC)	15.64%
Revenue Per Employee	6.99M
Profits Per Employee	1.15M
Employee Count	5,311
Asset Turnover	0.95
Inventory Turnover	2.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.44% in the last 52 weeks. The beta is -0.04, so J. B. Chemicals & Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	+16.44%
50-Day Moving Average	1,842.62
200-Day Moving Average	1,797.00
Relative Strength Index (RSI)	42.06
Average Volume (20 Days)	128,491

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, J. B. Chemicals & Pharmaceuticals had revenue of INR 37.11 billion and earned 6.11 billion in profits. Earnings per share was 38.43.

Revenue	37.11B
Gross Profit	24.27B
Operating Income	8.11B
Pretax Income	8.25B
Net Income	6.11B
EBITDA	9.65B
EBIT	8.11B
Earnings Per Share (EPS)	38.43

Full Income Statement

Balance Sheet

The company has 4.17 billion in cash and 1.00 billion in debt, giving a net cash position of 3.17 billion.

Cash & Cash Equivalents	4.17B
Total Debt	1.00B
Net Cash	3.17B
Net Cash Per Share	n/a
Equity (Book Value)	32.12B
Book Value Per Share	206.83
Working Capital	12.91B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.45 billion and capital expenditures -726.43 million, giving a free cash flow of 6.72 billion.

Operating Cash Flow	7.45B
Capital Expenditures	-726.43M
Free Cash Flow	6.72B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 65.40%, with operating and profit margins of 21.84% and 16.47%.

Gross Margin	65.40%
Operating Margin	21.84%
Pretax Margin	22.23%
Profit Margin	16.47%
EBITDA Margin	26.00%
EBIT Margin	21.84%
FCF Margin	18.12%

Dividends & Yields

J. B. Chemicals & Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	38.03%
Years of Dividend Growth	1
Payout Ratio	31.11%
Buyback Yield	-0.87%
Shareholder Yield	-0.87%
Earnings Yield	2.20%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on September 18, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 18, 2023
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a